Provider review
Remote Pharmacy review
Sells the GLP-1 as a daily tablet under the tongue, not a weekly injection.
Both molecules are compounded sublingual tablets taken once a day. That removes the needle, and with it the thing a low-dose patient usually relies on — the ability to draw a fraction of a syringe.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Remote Pharmacy
$167/mo sema · $229.99/mo tirz, sublingual tablets
- Vs median
- $2/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is an oral-first seller, and the route is the whole story. Semaglutide and tirzepatide both arrive as compounded tablets dissolved under the tongue once a day rather than injected once a week, which is genuinely what a lot of readers say they want. Weigh what it costs you, though, and it is not only the price. A tablet is a fixed unit: you take what was made or you do not, so taking a fraction stops being a decision you make with a syringe and becomes a product the seller has to offer. Neither published figure is attached to a dose, both are quoted as floors, and there is no ladder to show what a larger one costs. The homepage also carries a weight-loss figure with no study, cohort or comparison behind it, which is worth reading as marketing rather than evidence.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You do not want to inject, and a daily tablet is worth more to you than a weekly one.
- You want both molecules available in the same format from one provider.
- You want the price visible before an intake rather than after.
Look elsewhere if
- You want to take a fraction of a dose. A tablet cannot be split the way a syringe can.
- You want a dose behind the price. Neither figure has one, and both are floors.
- You weigh outcome claims. The weight-loss figure on the homepage has no study behind it.
What it actually costs
Price as published
Compounded semaglutide tablets "As low as $167/Month" and compounded tirzepatide tablets "As low as $229.99/Month", both described as "taken sublingually once a day" rather than injected weekly · both figures are "as low as" with no ladder published, and a daily oral route is not the route the trials behind these molecules used · the site advertises that its "patients on semaglutide lost 20lbs in 6 months", a claim with no study or cohort size attached
- Vs median
- $2/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. There is no low-dose product, and the route removes the usual workaround: a daily sublingual tablet cannot be split the way a syringe can, so taking a fraction depends entirely on the seller offering a smaller tablet. Neither published figure is attached to a dose, so a microdoser cannot price their own regime even in principle.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Sublingual tablets rather than injections, which removes the needle for readers who want that.
- Both prices are published before any intake, for both molecules.
- Prices sit meaningfully below the brand-name cash route for the same active ingredients.
Pharmacy, labs and oversight
Remote Pharmacy dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Remote Pharmacy publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Remote Pharmacy is an oral-first seller: its semaglutide and tirzepatide are compounded sublingual tablets taken once a day, not weekly injections, and that changes the calculation for anyone reading this page. A daily tablet removes the needle, which is the reason most people ask about orals in the first place. It also removes the thing a microdoser relies on — the ability to draw a fraction of a syringe. You take the tablet the manufacturer made or you do not, so a low dose has to be a product the seller offers rather than a decision you make at the point of injection. Neither price is tied to a dose, both are "as low as", and the weight-loss figure on the homepage is offered without a study, a cohort or a timeframe beyond the headline.
The honest cons
A daily tablet cannot be split the way a syringe can, so a low dose depends on the seller offering one.
- Both figures are "as low as" with no ladder or ceiling published, and no dose is attached to either.
- The "lost 20lbs in 6 months" claim carries no study, cohort size or comparison group.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Remote Pharmacy is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#154 of 373
Ordered with the companies that pay us first, and Remote Pharmacy is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.